CenterBook Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.61M Buy
+30,474
New +$2.98M 0.12% 218
2025
Q1
– Sell
-210,370
Closed -$9.44M – 504
2024
Q4
$9.44M Sell
210,370
-45,859
-18% -$2.57M 0.56% 39
2024
Q3
$16.1M Buy
256,229
+124,945
+95% +$7.29M 0.99% 19
2024
Q2
$7.75M Buy
131,284
+44,695
+52% +$2.8M 0.48% 52
2024
Q1
$6.91M Sell
86,589
-86,835
-50% -$6.63M 0.48% 56
2023
Q4
$13.7M Buy
173,424
+155,689
+878% +$11.1M 1.67% 3
2023
Q3
$1.24M Sell
17,735
-802
-4% -$56.8K 0.15% 215
2023
Q2
$1.28M Sell
18,537
-2,757
-13% -$196K 0.16% 213
2023
Q1
$1.58M Buy
21,294
+2,689
+14% +$225K 0.22% 152
2022
Q4
$1.73M Buy
18,605
+8,291
+80% +$800K 0.29% 125
2022
Q3
$984K Buy
+10,314
New +$1.02M 0.19% 180

Other funds holding CVS

CenterBook Partners's CVS Position: Q3 2026 in Review

CenterBook Partners opened a new position in CVS Health (CVS) in Q3 2026: 30,474 shares worth $2.61M. The stake represents 0.12% of the portfolio and ranks #218 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in CVS as recently as Q4 2024.

CenterBook Partners first reported a position in CVS in Q3 2022 and has held it in 11 quarters since. The position peaked at $16.1M in Q3 2024. 1,998 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • CenterBook Partners held 30,474 shares of CVS Health worth $2.61M as of Q3 2026.
  • CVS Health was a new CenterBook Partners position in Q3 2026.
  • CVS Health made up 0.12% of CenterBook Partners's portfolio in Q3 2026, its #218 holding.
  • CenterBook Partners first reported a position in CVS Health in Q3 2022 and has held it in 11 quarters since.
  • CenterBook Partners's CVS Health position peaked at $16.1M in Q3 2024.
  • 1,998 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.